In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.

We tested CI-919 (AT-2266), a nalidixic acid analog, against 555 gram-positive and gram-negative bacteria, using microbroth or agar dilution methods. The activity of CI-919 was compared with those of cephalosporins, tobramycin, ticarcillin, dicloxacillin, rifampin, chloramphenicol, ampicillin, and t...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Chartrand, S A, Scribner, R K, Weber, A H, Welch, D F, Marks, M I
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1983
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC184783/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6223577/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.23.5.658
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!